Cerebral Amyloid Angiopathy: emerging concepts
Scientific Conference at the University of Iceland in Reykjavik 8 - 11 August 2007.

Cerebral amyloid angiopathy (CAA) has turned out to be not only a simple risk factor for hemorrhagic stroke but also directly influencing brain function and the development of dementia, including Alzheimer disease, ischemic vascular and mixed dementias. To cover this new wealth of information a virtual mini-symposium was recently published (see Brain Pathology, 2006, volume 16) and will now be followed up by a symposium on CAA in Iceland, where the first familial form of CAA was described in 1935.

Members of the preliminary scientific advisory committee: Anders Grubb, Mathias Jucker, Astridur Palsdottir, Elias Olafsson

Confirmed invited speakers:
Jorge Ghiso, USA
Steven M. Greenberg, USA
Anders Grubb, Sweden
John Hardy, USA
Mathias Jucker, Germany
Efrat Levy, USA
Marion Maat-Schieman, The Netherlands
Harry Vinters, USA
Masahito Yamada, Japan



Organizing committee:

Ástríður Pálsdóttir
Elías Ólafsson                         
Ásbjörg Ósk Snorradóttir
Birkir Þór Bragason

Preliminary sessions include the following:
Animal models,
Pathogenesis,
Amyloid (Abeta, ACys, ATTR, AGel, ABri, ADan) formation and clearance,
Genetics,
Treatments,
Epidemiology and risk factors,
3D structures of amyloid.
 
 
 
©2006 Cinq-grafík.


AGTC HITS COUNTER v3.1